Recurrent urinary tract infection (rUTI) coping skills contribute to perceived health status and well-being, especially among younger and/or lower socioeconomic patients at greater risk for poor ...
Sept 2 (Reuters) - Drugmaker Tetraphase Pharmaceutical Inc said its experimental drug to treat complicated urinary tract infections (UTI) compared favorably to standard treatment in the first portion ...
inews.co.uk on MSN
Chronic UTI sufferers look forward to first new antibiotic in decades
The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is “first-in-its-class”, which means it uses a unique mechanism to treat UTIs, ...
Urinary tract infections (UTIs) are among the world’s most common bacterial maladies. Approximately 12 percent of men and roughly half of all women experience a UTI in their lifetime. Up to 44 percent ...
* Projects ongoing phase 1b study evaluating omadacycline in treatment of uuti will report data in q4 2016 Sign up here. * New revised estimate reflects better-than-anticipated enrollment performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback